Literature DB >> 28859758

Adoption of Sacubitril/Valsartan Must Take Into Account Different Heart Failure Patient Types.

Giuseppe Di Tano, Luca Bettari.   

Abstract

Entities:  

Year:  2017        PMID： 28859758     DOI： 10.1016/j.jchf.2017.06.011

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN： 2213-1779            Impact factor:   12.035


× No keyword cloud information.
  2 in total

1.  Safety of sacubitril/valsartan initiated during hospitalization: data from a non-selected cohort.

Authors:  Juan Carlos López-Azor; Lourdes Vicent; María Jesús Valero-Masa; Alberto Esteban-Fernández; Manuel Gómez-Bueno; Ángel Pérez; Pablo Díez-Villanueva; Javier De-Juan; Ángel Manuel-Iniesta; Ramón Bover; Susana Del Prado; Manuel Martínez-Sellés
Journal:  ESC Heart Fail       Date:  2019-11-08

2.  A Simple Score to Identify Super-Responders to Sacubitril/Valsartan in Ambulatory Patients With Heart Failure.

Authors:  Carles Moliner-Abós; Diana Mojón Álvarez; Mercedes Rivas-Lasarte; Laia Carla Belarte; Julia Pamies Besora; Eduard Solé-González; Paula Fluvià-Brugues; Isabel Zegrí-Reiriz; Laura López López; Vicens Brossa; Maria José Pirla; Nuria Mesado; Sonia Mirabet; Eulàlia Roig; Jesús Álvarez-García
Journal:  Front Physiol       Date:  2021-02-18       Impact factor: 4.566
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.